CAD and neoplasm: The data revealed a decrease in tumor growth in the CAD-knockdown cell-derived xenograft mouse model compared with the control (SC vs shRNA1#, P < 0.01; SC vs shRNA3#, P < 0.001; Fig. S5C–E).